Both in Surgical Instruments
Pulmonx vs LENSAR
Over the past year LUNG returned +20.0% and LNSR returned −43.6%; their daily moves had a correlation of 0.09.
LUNG +20.0% LNSR −43.6%Growth of $1, one year, split-adjusted
| Metric | LUNG | LNSR |
|---|---|---|
| Price | $1.98 | $6.90 |
| Market cap | $85.0M | $84.8M |
| Today | +1.02% | +0.29% |
| 1 month | −16.8% | −16.9% |
| 6 months | +67.8% | +17.5% |
| Year to date | −10.4% | −40.7% |
| 1 year | +13.8% | −44.1% |
| Revenue growth (YoY) | −4.6% | +18.4% |
| Gross margin | 78.0% | 59.3% |
| Net margin | −44.3% | 10.7% |
| P/E (TTM) | — | 5.5× |
| Price / sales | 1.0× | 1.4× |
| Net cash | $18.3M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 99.4% | 72.2% |
| Short % of float | 2.2% | 4.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).